Bots Portfolio News Brokers Calendar Rankings AI Analysis

🔍

🔔

ZivFin

A global finance community where investors connect without language barriers.

⚠️ All information on ZivFin is not investment advice. Stock data is delayed by 15 minutes. Investment decisions are your own responsibility.

🏠Home 💬Community 🤖Bots 📊Portfolio 📰News

Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat - Reuters | ZivFin News | ZivFin

← Back to News

Home/News/Boehringer-Zealand's obesity drug shows promise in...

Market

Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat - Reuters

Reuters2026.06.07Source: news.google.com ↗

Boehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat Reuters

← Back to News

Was this article helpful?

Community

Loading comments...

Market

Forget SCHD: DGRO’s Looser Quality Filter Has Quietly Delivered Higher Total Returns Over the Last Decade

Yahoo2026.06.07

For a 59-year-old pre-retiree sitting on a six-figure dividend core, the choice between iShares Core Dividend Growth ETF (NYSEARCA:DGRO) and Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) usually gets framed as a yield contest. SCHD pays more today. The quieter story is that DGRO has delivered 250% over the past ten years versus SCHD’s 233%, and ... Forget SCHD: DGRO’s Looser Quality Filter Has Quietly Delivered Higher Total Returns Over the Last Decade

More News

Market

Netflix’s Underperforming Stock Needs a New Story. It Can’t Be AI.

Yahoo2026.06.07

Netflix's stock has been underperforming for a year now. The company needs to come up with a new story to win over markets.

More News

Market

Trump storms out of interview after being challenged about election fraud claims, DOJ fund

CNBC2026.06.07

The president said he would like to see the weaponization fund proceed despite setbacks.